Current hematologic malignancy reportsHumansMyelodysplastic SyndromesMolecular Targeted TherapyGenomicsMutation
Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies.
Shirley S Mo, Amy E DeZern
Published: 202510.1007/s11899-025-00762-1
Abstract
PURPOSE OF REVIEW: Advances in modern molecular and genomic testing have spurred tremendous progress in our understanding of MDS pathogenesis. Here we review common diagnostic methods, the evolving multi-omics landscape of MDS, molecular subtypes, an…
Preview only. Read the full abstract at the source